US 12331124
ALK2 antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 12331124 (ALK2 antibodies and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P19/00, A61P19/10